Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / PFM Health Sciences, LP
Form 13F · Q2 2026

PFM Health Sciences, LP

CIK 1442756申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$11.7亿
申报组合市值
98
持仓数量
12
Quarters on record
Top 50
持仓数量

PFM Health Sciences, LP——持仓

共 98 个持仓中的前 50 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1ASND Ascendis Pharma A/S233,171—$6219万5.3%
2AXSM Axsome Therapeutics Inc.219,596−16.9%$5375万4.6%
3LLY Eli Lilly & Co39,258−40.3%$4709万4.0%
4JAZZ Jazz Pharmaceuticals Plc160,768−9.8%$3874万3.3%
5HUM Humana Inc94,375—$3749万3.2%
6UNH Unitedhealth Group Inc88,276+52.1%$3669万3.1%
7NBIX Neurocrine Biosciences Inc213,407−1.1%$3597万3.1%
8INBX Inhibrx Biosciences Inc308,385+1.0%$2922万2.5%
9UTHR United Therapeutics Corp Del49,991+25.6%$2709万2.3%
10RVMD Revolution Medicines Inc143,222+1.7%$2682万2.3%
11ICLR Icon Pub Ltd Co136,482+137.4%$2371万2.0%
12THC Tenet Healthcare Corp126,572−68.2%$2368万2.0%
13EW Edwards Lifesciences Corp250,453−1.6%$2266万1.9%
14WAT Waters Corp59,825+50.5%$2244万1.9%
15PEN Penumbra Inc60,221−56.9%$1901万1.6%
16BBIO Bridgebio Pharma Inc253,358−1.7%$1887万1.6%
17SYK Stryker Corporation56,637+157.9%$1783万1.5%
18MTD Mettler Toledo International13,344—$1705万1.5%
19INDIVIOR PHARMACEUTICALS INC Indivior Pharmaceuticals Inc401,208−30.2%$1646万1.4%
20MRK Merck & Co Inc127,118—$1633万1.4%
21CYTK Cytokinetics Inc191,686—$1633万1.4%
22LNTH Lantheus Hldgs Inc146,403—$1624万1.4%
23CNC Centene Corp Del248,867−5.5%$1597万1.4%
24COO Cooper Cos Inc220,890+30.1%$1584万1.4%
25MDGL Madrigal Pharmaceuticals Inc29,313−14.2%$1574万1.4%
26ACHC Acadia Healthcare Company In524,934−9.9%$1550万1.3%
27ORKA Oruka Therapeutics Inc158,825−8.7%$1512万1.3%
28OSCR Oscar Health Inc519,016+3.8%$1480万1.3%
29TMO Thermo Fisher Scientific Inc28,496+92.1%$1429万1.2%
30CVS Cvs Health Corp137,457—$1422万1.2%
31MMSI Merit Med Sys Inc197,038+21.3%$1366万1.2%
32PRAX Praxis Precision Medicines I38,575+8.9%$1291万1.1%
33CLDX Celldex Therapeutics Inc New342,751+5.5%$1275万1.1%
34NVO Novo-Nordisk A S265,016+34.4%$1270万1.1%
35ITGR Integer Hldgs Corp126,669−6.2%$1184万1.0%
36DNTH Dianthus Therapeutics Inc121,222−29.6%$1182万1.0%
37DFTX Definium Therapeutics Inc249,020+21.3%$1171万1.0%
38GILD Gilead Sciences Inc90,858—$1148万1.0%
39RYTM Rhythm Pharmaceuticals Inc101,550−25.7%$1128万1.0%
40HSIC Schein Henry Inc134,423−12.2%$1123万1.0%
41ARWR Arrowhead Pharmaceuticals In131,667+104.8%$1073万0.9%
42TNGX Tango Therapeutics Inc326,047−19.7%$1019万0.9%
43TFX Teleflex Incorporated79,708—$1010万0.9%
44VKTX Viking Therapeutics Inc255,330−3.0%$996万0.9%
45BTSG Brightspring Health Svcs Inc141,914−24.2%$990万0.8%
46VERA Vera Therapeutics Inc224,289+28.3%$962万0.8%
47ROIV Roivant Sciences Ltd268,008+29.2%$948万0.8%
48CGON Cg Oncology Inc128,286−22.7%$911万0.8%
49AMRX Amneal Pharmaceuticals Inc480,715−48.3%$832万0.7%
50EPRX Eupraxia Pharmaceuticals Inc1.2M+123.8%$800万0.7%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。